文献速递神经肿瘤

表达PDGFB和靶向Cdkn2a短发夹RNA的重组慢病毒驱动的前神经型胶质母细胞瘤小鼠模型

A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma.
PubMed 文献 · Neuro Oncol · 2018-01-01

研究设计重组慢病毒表达PDGFB和靶向Cdkn2a的短发夹RNA,立体定向注射至成年免疫健全小鼠齿状回诱导胶质瘤发生,并共表达CreERT2以便在转导细胞中删除floxed基因。注射后一周齿状回显示细胞增多,随后发展为具有胶质母细胞瘤病理特征的肿瘤,中位生存期为注射后77天,转录组分析显示前神经型基因表达特征。该模型允许在体内便捷测试肿瘤细胞基因功能,并快速产生大量免疫健全荷瘤小鼠用于临床前治疗评价。

要点

  • 重组慢病毒共表达PDGFB和靶向Cdkn2a的短发夹RNA,注射至成年免疫健全小鼠齿状回诱导胶质瘤。
  • 注射后一周齿状回显示细胞增多,随后发展为具有胶质母细胞瘤病理特征的肿瘤,中位生存期77天。
  • 肿瘤转录组分析显示前神经型基因表达特征,模型可用于体内基因功能测试和临床前治疗评价。

核心结论

  • 基于人胶质母细胞瘤中观察到的遗传改变,研究构建了一种新型前神经型胶质母细胞瘤小鼠模型。
  • 该模型保留转基因小鼠的许多优势,允许在体内便捷测试肿瘤细胞基因功能,并快速产生大量免疫健全荷瘤小鼠用于临床前治疗评价。

研究设计与样本

  • 研究设计重组慢病毒表达PDGFB和靶向Cdkn2a的短发夹RNA,立体定向注射至成年免疫健全小鼠齿状回诱导胶质瘤发生。
  • 病毒共表达CreERT2与PDGFB,允许在转导细胞中特异性删除floxed基因;另设计共表达增强绿色荧光蛋白、PDGFB和CreERT2的版本以可视化转导细胞。

主要发现

  • 注射小鼠齿状回在注射后一周显示细胞增多,随后发展为具有胶质母细胞瘤病理特征的肿瘤,中位生存期为注射后77天。
  • 肿瘤转录组分析显示前神经型基因表达特征。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mouse models of glioblastoma (GBM), the most aggressive primary brain tumor, are critical for understanding GBM pathology and can contribute to the preclinical evaluation of therapeutic agents. Platelet-derived growth factor (PDGF) signaling has been implicated in the development and pathogenesis of GBM, specifically the proneural subtype. Although multiple mouse models of PDGF-driven glioma have been described, they require transgenic mice engineered to activate PDGF signaling and/or impair tumor suppressor genes and typically represent lower-grade glioma. METHODS: We designed recombinant lentiviruses expressing both PDGFB and a short hairpin RNA targeting Cdkn2a to induce gliomagenesis following stereotactic injection into the dentate gyrus of adult immunocompetent mice. We engineered these viruses to coexpress CreERT2 with PDGFB, allowing for deletion of floxed genes specifically in transduced cells, and designed another version of this recombinant lentivirus in which enhanced green fluorescent protein was coexpressed with PDGFB and CreERT2 to visualize transduced cells. RESULTS: The dentate gyrus of injected mice showed hypercellularity one week post-injection and subsequently developed bona fide tumors with the pathologic hallmarks of GBM leading to a median survival of 77 days post-injection. Transcriptomic analysis of these tumors revealed a proneural gene expression signature. CONCLUSION: Informed by the genetic alterations observed in human GBM, we engineered a novel mouse model of proneural GBM. While reflecting many of the advantages of transgenic mice, this model allows for the facile in vivo testing of gene function in tumor cells and makes possible the rapid production of large numbers of immunocompetent tumor-bearing mice for preclinical testing of therapeutics.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Rahme GJ, Luikart BW, Cheng C, et al. A recombinant lentiviral PDGF-driven mouse model of proneural glioblastoma. Neuro Oncol. 2018. PMID: 29016807. doi:10.1093/neuonc/nox129

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。